CMH Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$17.3M Buy
14,385
+308
+2% +$315K 2.63% 10
2026
Q1
$12.9M Sell
14,077
-234
-2% -$237K 2.22% 12
2025
Q4
$15.4M Sell
14,311
-465
-3% -$445K 3.29% 8
2025
Q3
$11.3M Buy
14,776
+2,314
+19% +$1.72M 2.4% 13
2025
Q2
$9.71M Buy
12,462
+165
+1% +$128K 2.26% 14
2025
Q1
$10.2M Sell
12,297
-1,575
-11% -$1.31M 2.54% 11
2024
Q4
$10.7M Buy
13,872
+552
+4% +$457K 2.45% 11
2024
Q3
$11.8M Sell
13,320
-367
-3% -$330K 2.78% 9
2024
Q2
$12.4M Buy
13,687
+102
+0.8% +$81.6K 3.05% 8
2024
Q1
$10.6M Sell
13,585
-1,778
-12% -$1.27M 2.69% 11
2023
Q4
$8.96M Sell
15,363
-190
-1% -$111K 2.17% 18
2023
Q3
$8.35M Sell
15,553
-9,135
-37% -$4.71M 2.34% 17
2023
Q2
$11.6M Buy
24,688
+373
+2% +$156K 3.11% 9
2023
Q1
$8.35M Buy
24,315
+10,512
+76% +$3.55M 2.41% 15
2022
Q4
$5.05M Sell
13,803
-101
-0.7% -$35.8K 1.62% 27
2022
Q3
$4.5M Buy
13,904
+379
+3% +$120K 1.65% 24
2022
Q2
$4.38M Sell
13,525
-6,660
-33% -$2M 1.59% 22
2022
Q1
$5.78M Buy
20,185
+228
+1% +$58.7K 1.78% 17
2021
Q4
$5.51M Buy
19,957
+253
+1% +$64.1K 1.66% 20
2021
Q3
$4.55M Buy
19,704
+298
+2% +$73.5K 1.49% 26
2021
Q2
$4.45M Buy
19,406
+1,530
+9% +$307K 1.49% 26
2021
Q1
$3.34M Buy
17,876
+1,288
+8% +$252K 1.26% 32
2020
Q4
$2.8M Buy
16,588
+368
+2% +$54.9K 1.03% 37
2020
Q3
$2.4M Buy
16,220
+1,750
+12% +$271K 1.03% 35
2020
Q2
$2.38M Sell
14,470
-969
-6% -$149K 1.13% 36
2020
Q1
$2.14M Buy
15,439
+1,698
+12% +$233K 1.25% 36
2019
Q4
$1.81M Buy
13,741
+130
+1% +$15.1K 0.93% 46
2019
Q3
$1.52M Buy
13,611
+735
+6% +$81.8K 0.86% 47
2019
Q2
$1.43M Sell
12,876
-470
-4% -$55.3K 0.84% 45
2019
Q1
$1.73M Sell
13,346
-3,045
-19% -$370K 1.05% 44
2018
Q4
$1.9M Sell
16,391
-1,692
-9% -$189K 1.14% 37
2018
Q3
$1.95M Buy
18,083
+270
+2% +$27K 1.02% 38
2018
Q2
$1.53M Buy
17,813
+235
+1% +$19.3K 0.87% 41
2018
Q1
$1.33M Buy
17,578
+490
+3% +$39.4K 0.9% 44
2017
Q4
$1.45M Buy
17,088
+25
+0.1% +$2.13K 0.96% 41
2017
Q3
$1.47M Sell
17,063
-25
-0.1% -$2.05K 1.09% 35
2017
Q2
$1.41M Sell
17,088
-55
-0.3% -$4.49K 1.13% 36
2017
Q1
$1.48M Sell
17,143
-47
-0.3% -$3.76K 1.16% 36
2016
Q4
$1.32M Buy
+17,190
New +$1.28M 1.15% 36

Other funds holding LLY

CMH Wealth Management's LLY Position: Q2 2026 in Review

CMH Wealth Management increased its Eli Lilly (LLY) stake by 2.2% in Q2 2026, buying an estimated $315K and bringing the position to 14,385 shares worth $17.3M. The position accounts for 2.63% of the portfolio, ranked #10.

CMH Wealth Management first reported a position in LLY in Q4 2016 and has held it in 39 quarters since. 841 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • CMH Wealth Management held 14,385 shares of Eli Lilly worth $17.3M as of Q2 2026.
  • CMH Wealth Management bought 308 Eli Lilly shares in Q2 2026, an estimated $315K.
  • Eli Lilly made up 2.63% of CMH Wealth Management's portfolio in Q2 2026, its #10 holding.
  • CMH Wealth Management first reported a position in Eli Lilly in Q4 2016 and has held it in 39 quarters since.
  • 841 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on CMH Wealth Management's 13F filing for Q2 2026, filed 9 Jul 2026.